Location History:
- Miami, FL (US) (2015 - 2018)
- New York, NY (US) (2014 - 2024)
Company Filing History:
5 out of 1,627 
3 out of 2,118 
2 out of 327 
Years Active: 2014-2024
Title: Adam B Braunschweig: Innovator in Antiviral Research
Introduction
Adam B Braunschweig is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of antiviral research, holding a total of 10 patents. His work focuses on developing compounds that exhibit antiviral properties, particularly against various viral infections.
Latest Patents
Among his latest patents, Braunschweig has developed carbohydrate-binding small molecules with antiviral activity. These compounds are based on a variety of heteroaromatic groups that have been found to be biologically active against viral infections. In some embodiments, he provides a dimeric compound with each monomer linked by a repeating glycol linking group. Additionally, he has created compounds that are specifically active against the Zika virus (ZIKV), showcasing the versatility and importance of his research.
Career Highlights
Braunschweig has had a distinguished career, working at prestigious institutions such as New York University and Northwestern University. His research has not only advanced scientific understanding but has also contributed to the development of potential therapeutic agents against viral diseases.
Collaborations
Throughout his career, Braunschweig has collaborated with notable colleagues, including Shudan Bian and Chad A Mirkin. These partnerships have further enriched his research and expanded the impact of his innovations.
Conclusion
Adam B Braunschweig is a key figure in the field of antiviral research, with a strong portfolio of patents that reflect his innovative spirit and dedication to combating viral infections. His contributions continue to influence the scientific community and pave the way for future advancements in antiviral therapies.